DnB Asset Management AS Buys 21,722 Shares of Insulet Co (NASDAQ:PODD) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Insulet (NASDAQ:PODD – Get Free Report) was upgraded by equities researchers at Robert W. Baird from a “neutral” rating to an “outperform” rating in a research report issued to clients and investors on Thursday, Marketbeat reports. The firm presently has a $238.00 price objective on the medical instruments supplier’s stock, up from their previous price […]
Formula Growth Ltd. decreased its position in shares of Insulet Co. (NASDAQ:PODD – Free Report) by 28.4% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 4,150 shares of the medical instruments supplier’s stock after selling 1,650 shares during the period. Formula […]
Capital Research Global Investors decreased its position in Insulet Co. (NASDAQ:PODD – Free Report) by 7.0% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 5,171,340 shares of the medical instruments supplier’s stock after selling 390,886 shares during the period. […]
Capital International Ltd. CA reduced its stake in Insulet Co. (NASDAQ:PODD – Free Report) by 6.3% during the 2nd quarter, Holdings Channel reports. The firm owned 44,062 shares of the medical instruments supplier’s stock after selling 2,965 shares during the period. Capital International Ltd. CA’s holdings in Insulet were worth $12,705,000 at the end of […]